Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone vs Spironolactone for Ascites in Liver Cirrhosis
NCT01801228Phase 2Withdrawn
- Start
- Feb 2013
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eplerenone in ascites. Planned start Feb 2013; status: withdrawn.
02
Drugs
eplerenone
03
Conditions
ascites
Beyond the preview
Go deeper on NCT01801228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01801228.